Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Permanyer
2022-07-01
|
| Seri Bilgileri: | Gaceta Mexicana de Oncología |
| Konular: | |
| Online Erişim: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|